Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin plus androgen deprivation in castration-resistant prostate cancer
2015-003720-32Phase 2Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of atorvastatin in prostate cancer (PCa), sponsored by NHS Greater Glasgow and Clyde. Started Mar 2016; status: completed.
02
Drugs
atorvastatin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2015-003720-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003720-32.